PubMed

Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up.

McMahon BJ, Bruden DL, Petersen KM, Bulkow LR, Parkinson AJ, Nainan O, Khristova M, Zanis C, Peters H, Margolis HS.

Ann Intern Med. 2005 Mar 1;142(5):333-41.PMID: 15738452 [PubMed - indexed for MEDLINE]Related articlesFree article

Persistence of antibody to hepatitis B and protection from disease among Alaska natives immunized at birth.

Dentinger CM, McMahon BJ, Butler JC, Dunaway CE, Zanis CL, Bulkow LR, Bruden DL, Nainan OV, Khristova ML, Hennessy TW, Parkinson AJ.

Pediatr Infect Dis J. 2005 Sep;24(9):786-92.PMID: 16148845 [PubMed - indexed for MEDLINE]Related articles

Response to hepatitis B vaccine in Alaska natives with chronic alcoholism compared with non-alcoholic control subjects.

McMahon BJ, Wainwright K, Bulkow L, Parkinson AJ, Lindenbaum M, Wainwright R, Helminiak C.

Am J Med. 1990 May;88(5):460-4.PMID: 2140010 [PubMed - indexed for MEDLINE]Related articles

Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.

Bialek SR, Bower WA, Novak R, Helgenberger L, Auerbach SB, Williams IT, Bell BP.

Pediatr Infect Dis J. 2008 Oct;27(10):881-5.PMID: 18756185 [PubMed - indexed for MEDLINE]Related articles

The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds.

Tsebe KV, Burnett RJ, Hlungwani NP, Sibara MM, Venter PA, Mphahlele MJ.

Vaccine. 2001 Jul 16;19(28-29):3919-26.PMID: 11427266 [PubMed - indexed for MEDLINE]Related articles

Increases in levels of antibody to hepatitis B surface antigen in an immunized population.

Bulkow LR, Wainwright RB, McMahon BJ, Parkinson AJ.

Clin Infect Dis. 1998 Apr;26(4):933-7.PMID: 9564478 [PubMed - indexed for MEDLINE]Related articles

Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.

Samandari T, Fiore AE, Negus S, Williams JL, Kuhnert W, McMahon BJ, Bell BP.

Pediatrics. 2007 Aug;120(2):e373-81. Epub 2007 Jul 16.PMID: 17636112 [PubMed - indexed for MEDLINE]Related articlesFree article

Levamisole treatment enhances protective antibody response to hepatitis B vaccination in hemodialysis patients.

Kayataş M.

Artif Organs. 2002 Jun;26(6):492-6.PMID: 12072104 [PubMed - indexed for MEDLINE]Related articles

Summaries for patients. Does hepatitis B vaccination protection continue after 15 years?

[No authors listed]

Ann Intern Med. 2005 Mar 1;142(5):I34. No abstract available. PMID: 15738447 [PubMed - indexed for MEDLINE]Related articlesFree article

18-year follow-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in children.

Yuen MF, Lim WL, Chan AO, Wong DK, Sum SS, Lai CL.

Clin Gastroenterol Hepatol. 2004 Oct;2(10):941-5.PMID: 15476159 [PubMed - indexed for MEDLINE]Related articles

Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination.

Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, Tsai KS, Chen DS.

Ann Intern Med. 2001 Nov 6;135(9):796-800.PMID: 11694104 [PubMed - indexed for MEDLINE]Related articlesFree article

Loss of hepatitis B immunity in hemodialysis patients acquired either naturally or after vaccination.

Tsouchnikas I, Dounousi E, Xanthopoulou K, Papakonstantinou S, Thomoglou V, Tsakiris D.

Clin Nephrol. 2007 Oct;68(4):228-34.PMID: 17969490 [PubMed - indexed for MEDLINE]Related articles

Anti-HBs responses in children vaccinated with different schedules of either plasma-derived or HBV DNA recombinant vaccine.

Da Villa G, Pelliccia MG, Peluso F, Ricciardi E, Sepe A.

Res Virol. 1997 Mar-Apr;148(2):109-14.PMID: 9108609 [PubMed - indexed for MEDLINE]Related articles

Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.

Wörns MA, Teufel A, Kanzler S, Shrestha A, Victor A, Otto G, Lohse AW, Galle PR, Höhler T.

Am J Gastroenterol. 2008 Jan;103(1):138-46. Epub 2007 Oct 26.PMID: 17970833 [PubMed - indexed for MEDLINE]Related articles

Further observations on the immune response to recombinant hepatitis B vaccine after administration to aboriginal and Torres Strait Island children.

Hanna JN, Faoagali JL, Buda PJ, Sheridan JW.

J Paediatr Child Health. 1997 Feb;33(1):67-70.PMID: 9069048 [PubMed - indexed for MEDLINE]Related articles

[Persistence of HB vaccine immune protection and response to hepatitis B booster immunization]

Li H, Li R, Liao S, Yang J, Zeng X.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1998 Feb;20(1):54-9. Chinese. PMID: 11367735 [PubMed - indexed for MEDLINE]Related articles

Anti-HBs profiles in children treated for neoplastic disease who had been vaccinated against hepatitis B postnatally or as infants.

Koltan S, Koltan A, Wysocki M, Debski R, Styczynski J.

J Hosp Infect. 2005 May;60(1):73-7.PMID: 15823661 [PubMed - indexed for MEDLINE]Related articles

Vaccination against hepatitis B and protection against chronic viral carriage in The Gambia.

Whittle HC, Inskip H, Hall AJ, Mendy M, Downes R, Hoare S.

Lancet. 1991 Mar 30;337(8744):747-50.PMID: 1672389 [PubMed - indexed for MEDLINE]Related articles

Persistence of anti-HBs in children vaccinated against viral hepatitis B in the first year of life: follow-up at 5 and 10 years.

Da Villa G, Peluso F, Picciotto L, Bencivenga M, Elia S, Pelliccia MG.

Vaccine. 1996 Nov;14(16):1503-5.PMID: 9014290 [PubMed - indexed for MEDLINE]Related articles

Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages.

Whittle HC, Maine N, Pilkington J, Mendy M, Fortuin M, Bunn J, Allison L, Howard C, Hall A.

Lancet. 1995 Apr 29;345(8957):1089-92.PMID: 7715343 [PubMed - indexed for MEDLINE]Related articles